Sage Therapeutics (SAGE) shares surged nearly 38% in recent Monday premarket activity after it said late Friday Biogen (BIIB) had submitted an unsolicited, nonbinding proposal to acquire all outstanding shares of the company not already owned for $7.22 a share.
Intra-Cellular Therapies (ITCI) stock rose nearly 35% after it signed a definitive deal to be acquired by Johnson & Johnson (JNJ) for $132 per share in cash for a total equity value of about $14.6 billion, the companies said Monday.
Pediatrix Medical Group (MD) shares rose nearly 16% after saying it appointed Executive Chair Mark Ordan as chief executive officer, effective immediately.
Molecular Partners (MOLN) stock jumped 22%, after it expanded its strategic partnership with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。